Description
A cardiotonic steroid that inhibits theNa+/K+-ATPase transporter (Kds = 42, 45, and 40 nM for the α1, α2, and α3 subunits, respectively); inhibits SRC-1 and SRC-3 at doses as low as 5 nM, promotes the degradation of SRC-3 protein, and inhibits cancer cell growth both in vitro and in vivo
Formal name: (3β,5β)-3,14-dihydroxy-bufa-20,22-dienolide
Synonyms: NSC 89595
Molecular weight: 386.5
CAS: 465-21-4
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Lipids|Sterol Lipids||Product Type|Biochemicals|Natural Products||Product Type|Biochemicals|Small Molecule Inhibitors|ATPases||Product Type|Biochemicals|Transporter & Exchanger Modulators||Research Area|Cancer|Cell Death|Apoptosis||Research Area|Cardiovascular System|Cardiovascular Diseases|Cardiomyopathy||Research Area|Cardiovascular System|Cardiovascular Diseases|Heart Failure||Research Area|Lipid Biochemistry|Sterol Lipids